A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia

MLA

Andrea Mannucci, et al. “A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia.” Drug Design, Development and Therapy, vol. 14, Mar. 2020, pp. 1177–89. EBSCOhost, https://doi.org/10.2147/dddt.s243787.

APA

Andrea Mannucci, Adnan Nagrial, Catello Somma, Jason D. Lickliter, Jianjun Zou, Mark Voskoboynik, Michael Millward, Tarek Meniawy, Lianshan Zhang, Katherine Woods, Peter Grimison, Michael Lahn, Surein Arulananda, Hui K Gan, Pablo Fernandez-Penas, Andreas Behren, Bo Gao, Michelle Harrison, Howard Kallender, & Stacey Luo. (2020). A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia. Drug Design, Development and Therapy, 14, 1177–1189. https://doi.org/10.2147/dddt.s243787

Chicago

Andrea Mannucci, Adnan Nagrial, Catello Somma, Jason D. Lickliter, Jianjun Zou, Mark Voskoboynik, Michael Millward, et al. 2020. “A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia.” Drug Design, Development and Therapy 14 (March): 1177–89. doi:10.2147/dddt.s243787.